MedTrace Logo

Retrospective Analysis of the Efficacy of Morphine Gel to Treat Pain Associated With Perineal RadioDermatitis

NCT07207889 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2025-10-06

No results posted yet for this study

Summary

Retrospective study evaluating the efficacy of a pharmacy-prepared Morphine gel used in clinics for the treatment of pain associated with perineal radiodermatitis. The main aim of this study is to evaluate the efficacy of Morphine Gel (MG) in pain management.

Conditions

  • Dermatitis, Radiation Induced

Interventions

DRUG

morphine chlorhydrate in intrasite gel

The use of Morphine gel to treat painfull perineal radiodermatitis is new. None clinical study was conducted to explore the efficacy of the morphine gel as local analgesic for these cutaneous toxicity due to radiotherapy

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Principal Investigators

  • Elodie LABEDADE · Institut Curie

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07207889 on ClinicalTrials.gov